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Abstract
Cis-acting regulatory sequence elements are sequences contained in the 30 and 50
untranslated region, introns, or coding regions of precursor RNAs and mature mRNAs
that are selectively recognized by a complementary set of one or more trans-acting
factors to regulate posttranscriptional gene expression. This chapter focuses on mam-
malian cis-acting regulatory elements that had been recently discovered in different
regions: pre-processed and mature. The chapter begins with an overview of two large
networks of mRNAs that contain conserved AU-rich elements (AREs) or GU-rich ele-
ments (GREs), and their role in mammalian cell physiology. Other, less conserved, cis-
acting elements and their functional role in different steps of RNA maturation and
metabolism will be discussed. The molecular characteristics of pathological cis-acting
sequences that rose from gene mutations or transcriptional aberrations are briefly
outlined, with the proposed approach to restore normal gene expression. Concise
models of the function of posttranscriptional regulatory networks within different cellu-
lar compartments conclude this chapter.
Keywords: cis-elements, posttranscriptional gene regulation, mRNA splicing,
translation, mRNA stability, decay, AU-rich elements (AREs) or GU-rich elements
(GREs)
1. Introduction
The control of gene expression is fundamental to mammalian cell life. Although much of this
control occurs at the level of transcription, posttranscriptional control is both prevalent and
momentous [1]. Work over the past quarter century has resulted in the identification of
unifying concepts in posttranscriptional regulation. One unifying concept states that posttran-
scriptional regulation is mediated by two major molecular components: cis-acting regulatory
sequence elements and trans-acting factors. Cis-acting regulatory sequence elements are sub-
sequences contained in the 50 untranslated region (UTR), 30 UTR, introns, and coding regions
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of precursor RNA and mature mRNA that are selectively recognized by a complementary set of
one or more trans-acting factors to regulate posttranscriptional gene expression. The lists of
conserved cis-elements have been expanding over the past decade, but the mechanisms of the
precise assembly of RNA-binding complexes in an orchestrated temporal and spatial manner
have not been comprehensively described. Conserved sequences within pre-mRNAs play a
major role in determining the mRNA’s configuration, stability, and ultimately the posttransla-
tional fate of protein products. Mammalian pre-mRNAs contain almost as much conserved
sequence as that ascribed to transcriptional regulatory elements, and many of these cis-elements
can be attributed to known molecular functions, as described in the following paragraphs.
Trans-acting factors include RNA-binding proteins (RNA-BPs) and microRNAs (miRNAs),
which are able to influence the fate of mRNA by controlling processes such as translation and
mRNA degradation (reviewed in Refs. [2–5]). The combinatorial interplay between RNA-BPs,
various miRNAs, and a given mRNA allows for the transcript-specific regulation critical to
many cellular decisions during cell division, cell quiescence, or cell senescence [6]. RNA-BP
classification is growing and becoming more defined as more structural data become available.
Significant progress has been made in defining RNA-binding domains, such as an RNA
recognition motif (RRM), zinc fingers, double-stranded RNA-binding domains, K homology
domains, pumilio homology domains, and others, that were recently reviewed in [7, 8].
In the pre-genomic era, very few cis-acting RNA sequences had been discovered, for example,
AU-rich elements (AREs) in the 30 UTR of cytokine mRNAs [9]. Advances in genomic method-
ologies escalated the discoveries and functional identifications of cis-acting sequences.
Microarray-based studies that evaluated mRNA stability and translation on a genome-wide
basis have provided valuable information about the role of posttranscriptional regulation of a
wide variety of transcripts that have an important physiological function [10–12]. Genome-
wide measurements of mRNA decay and bioinformatic sequence motif discovery methods
were used to identify the GU-rich element (GRE) as a highly conserved sequence that was
enriched in the 30 UTR and other regions of mRNA transcripts [13]. Various experimental
approaches have been developed to understand the functional importance of cis-acting
sequence interactions and the network of transcripts that they regulate. One of the most widely
used techniques involves immunopurification of specific RNA-binding proteins from cellular
extracts followed by a high-throughput analysis of the co-purified RNA species [14]. The
coupling of this technique to powerful bioinformatic analysis has led researchers to under-
stand the binding specificity of cis-acting elements [15]. The advent of new technology such as
next generation sequencing (NGS) and chemical cross-linking procedures has allowed for fine-
scale mapping of cis-binding motifs as well as for the refinement of RNA-binding protein-
binding sites. A variety of methods have been developed to identify the in vivo target RNAs
of a given RNA-BP, including microarray (Chip) or high-throughput sequencing (Seq) of
RNA isolated by RNA-BP immunoprecipitation (RIP-Chip, RIP-Seq, and RIPiT-Seq), photo-
activatable ribonucleoside-enhanced cross-linking and immunoprecipitation (RIP-CLIP),
individual-nucleotide resolution cross-linking and immunoprecipitation (iCLIP), or UV cross-
linking and immunoprecipitation (HiTS-CLIP) [16–20]. These methodologies involve RNA
immunoprecipitation techniques with RNA-BP, followed by the NGS analysis of associated
mRNA or microRNA transcripts and genome-wide identification of cis-elements within RNA
Gene Expression and Regulation in Mammalian Cells - Transcription From General Aspects36
target transcripts. More novel techniques such as sequence-specificity landscapes (SEQRS),
HiTS-Kin/HiTS-EQ, and digestion optimized (DO)RIP-Seq focus on the identification of multi-
ple trans-acting factors [7, 21, 22]. These techniques allow for the evaluation of the specificity of
cellular RNA-BP/RNA-binding patterns from cell lysates under different conditions and might
aid in the interpretation of a multiprotein complex formation and RNA-BP competition for
RNA substrate. Identified RNA-binding complexes can then be isolated and interrogated
in vitro using structural and cell-based reporter assays.
This chapter focuses on mammalian cis-acting regulatory elements that have been recently
discovered in different regions of mRNA: preprocessed and mature. First, we summarize
recent observations of two large networks of mRNAs that contain conserved AREs or GREs
in their pre-mRNA splicing sites, polyadenylation sites, and 30/50 UTRs. We outline the known
roles for ARE and GRE in regulation of mRNA stability or translation and their role in
mammalian cell physiology, with a particular emphasis on their role in the dynamic response
toward environmental and developmental signals. Second, we describe advances in the iden-
tification of other conserved cis-acting elements and their functional role in different steps of
RNAmaturation and metabolism. We briefly outline the molecular characteristics of patholog-
ical cis-acting sequences raised from gene mutation or transcriptional aberration and overview
novel approaches to restore normal gene expression. We conclude with an overview of a
concise predictive model of the function of posttranscriptional regulatory networks within
different cellular compartments.
2. AU-rich element (ARE)
It was noted over a quarter of a century ago that mRNAs exhibit substantial variations in
turnover rate upon exposure to different cell stimuli [23–25]. Of the prominent discoveries in
the mammalian cis-acting elements field, the AU-rich element was the most notable as it was
the most robust determinant of mRNA instability in cytokines and early response genes [26].
Insight into the biological significance and physiological function of ARE as a coordinate
regulator of posttranscriptional network was revealed through the experimental identification
of ELAVL1 (HuR) and ZNF36 (TTP) proteins [27–29]. The structure of AREs is defined as a
repeating pentamer (AUUUA) with 1 or 2 A to U substitutions [9]. Bioinformatic searches
throughout the human transcriptome have provided computational estimation of sequence
characteristics and nucleotide lengths of ARE sequences required for mRNA to be unstable [30,
31]. The number of pentamers has an additive effect on mRNA decay and deadenylation
processes. AREs are classified into five clusters depending on their sequence content and
position of A or U. Cluster I AREs contain up to five copies of AUUUA motifs with a nearby
U-rich region and cause synchronous RNA deadenylation [32]. Cluster II AREs are composed
of at least two overlapping copies of the AUUUA with an adjacent (U/A) nonamer region and
cause asynchronous deadenylation. Clusters III through V AREs were identified to contain
more U-rich regions and were rather ‘poorly structured’ (Table 1), with an inconsistent
deadenylation pattern. This classification system has proved to be helpful in understanding
the observed behavior and function of ARE-containing transcripts [25].
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Trans-acting factors Functional
categories
ARE sequences Cluster GRE sequences Functional categories Trans-acting
factors
ELAVL1
ELAVL2
ZFP36
KSRP
TIA1, TIAL1
HNRNPC1
HNRNPD GAPDH
Cytokines,
Chemokines
Growth
factors;
Cell signaling;
Apoptosis
AUUUAUUUAUUUAUUUAUUUA I GUUUGUUUGUUUGUUUGUUUG Transcription factors;
Cell cycle;
Cell metabolism; Cell–cell
communication
regulators
CELF1
CELF2
ELAVL4
RBM38
TARDBP
FUS
AUUUAUUUAUUUAUUUA II GUUUGUUUGUUUGUUUG
WAUUUAUUUAUUUAW III GUKUGUUUGUKUG
WWAUUUAUUUAWW IV KKGUUUGUUUGKK
WWWWAUUUAWWWW V KKKU/GUKUG/UKKK
ARE and GRE mRNAs were clustered (with allowance for one mismatch) into five subclasses based on the number of pentameric repeats (AUUUA or GUUUG) and
surrounding sequences. W indicates A or U. K indicates G or U. This table was made based on previous publications [33, 47, 74, 75, 77]. ARE- or GRE-containing transcripts
in clusters I and II contain four or more overlapping AUUUA or GUUUG pentamers and are each represented by only a few hundred transcripts. Most of the transcripts in
these clusters are cytokines, transcription factors, and early response genes. Clusters III through V contain shorter sequences with less sequence repetition and contain up to
several thousand members.
Trans-acting factors that bind to ARE (far left column) or GRE (far right column) are: ELAVL1,2,4 (embryonic lethal, abnormal vision)-like 1,2,4; ZFP36, zinc finger protein
36; TIA1, T-cell intracellular antigen 1; TIAL1, TIA1-cytotoxic granule associated RNA-binding protein like 1; KSRP, KH-type splicing regulatory protein; HNRNP C1,D,
heterogeneous nuclear ribonucleoprotein C1, D; GAPDH, Glyceraldehyde 3-phosphate dehydrogenase; CELF1,2, CUGBP-ELAV-like family member 1,2; RBM38, RNA-
binding protein 38; TARDBP, Tat RNA regulatory element (TAR) DNA-binding protein; FUS, fused in sarcoma.
Table 1. Structural and functional comparison of AU-rich and GU-rich elements.
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Genome-wide analyses of mRNA transcript half-lives showed that many labile transcripts con-
tain conserved ARE sequence elements in their 30 UTRs [21]. Overall, 30 UTR-ARE-containing
transcripts represent approximately 5% of the transcriptome [33]. Human mRNAs encoding
cytokines and members of the NFkB cascade are particularly enriched for AREs (Table 1). AREs
play decisive roles in regulating the effects of cytokines on inflammatory responses since muta-
tion of the ARE in cytokines such as TNF-alpha, IFNG, or IRF5 [34] resulted in profound
autoimmune-like inflammatory syndrome [35, 36]. In general, transcripts containing functional
AREs have short half-lives, although they can be rapidly stabilized in different cell types or
stimulation conditions through complex posttranscriptional mechanisms involving trans-acting
factors [10, 37]. Numerous trans-binding factors interact with AREs (e.g., ELAVLs, ZFP36, KSRP,
TIA1, TIAL1, HRNPC1, and others, which are described in other chapters of this book) and
determine the outcomes for harboring ARE transcripts. The majority of these proteins shuttle
between the cytoplasm and the nucleus, where they can affect RNA splicing and 30-end
processing, in addition to altering the rate of decay in the cytoplasm [38]. In this respect, it is
interesting to note that AREs are also found in intronic regions of pre-mRNAs [39–42]. This
observation leads to the speculation that trans-acting factors could bind ARE in the nucleus and
fulfill a function that is different from their cytoplasmic one. Furthermore, a considerable overlap
in the binding sites for ARE-BP with other cis-elements, such as GU-rich and poly-U sequences,
warrants further investigation since the formation of secondary RNA structure might involve all
of the above and subsequently rule the coordinate behavior of RNA-BPs in different cellular
compartments or under different cellular stimuli [43–45].
3. GU-rich element (GRE)
GU-rich elements (GREs) are recognized as essential regulators of mRNA splicing, stability,
and translation in mammalian cells [11, 46]. GU-rich containing RNAs represent approxi-
mately 8% of transcripts of the human transcriptome [47]. Genome-wide analyses of mRNA
decay rates allowed for discovery of non-ARE-containing cohorts of mRNAs that exhibited
rapid turnover. Computational de novo motif search identified conserved sequence elements in
their 30 UTRs in a form of a consensus U(GUUUG)n sequences [13] or GU repeats [48]. These
elements were first tested in vivo in reporter systems and conferred instability onto reporter
mRNAs. A well-utilized rabbit beta-globin reporter system identified GREs as sequences that
regulate the decay of exogenously expressed GRE-containing reporter transcripts within cells
[13]. Further verification of GRE-mediated mRNA decay came from the observation that
siRNA-mediated knockdown of protein CELF1 led to the stabilization of GRE-containing
beta-globin reporter transcripts as well as endogenous GRE-containing transcripts [49–51].
These studies also showed that both GU-rich sequences and GU repeats are also enriched in
unstable mRNAs, though a number of GUUUG pentamers in the GRE do not seem to correlate
with the mRNA decay rate. GREs were subsequently tested for RNA-binding specificities to
CELF1 and CELF2 proteins in systemic evolution of ligands exponential enrichment, yeast
three-hybrid system selection methods, and surface plasmon resonance quantitative binding
assays, revealing that the CELF family preferentially bind to 15–22 nucleotide GU-rich RNA
sequences [52–54]. Several studies reported that other proteins bind to very short UG repeats
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with higher affinity, but dropped once the repeats became longer than 15 nucleotides (e.g.,
TARDBP, FUS) [55, 56]. Binding to dispersed GRE pentanucleotides (mostly by RRM-
containing proteins) have also been reported, although unified functional consequences of it
are just beginning to emerge (refer to a comprehensive review in Ref. [57]).
Using whole genome microarrays and high-throughput NGS methodologies, GRE targets
have been identified in a number of mammalian cells, for example, resting and activated
human T cells, mouse brain cells, and myoblasts or human malignant cell lines [48, 58–61].
The majority of studies extensively characterized GREs as binding sites located predominantly
in 30 UTRs and caused mRNA decay (or stabilization) depending upon the cellular and
environmental context [62]. These UG-rich sequences serve as binding sites for the family of
CELF and ELAVL proteins. Interestingly, these two families of RNA-binding proteins share
over 80% of sequence conservation within RNA recognition motifs but cause opposite out-
comes: the CELF family binding to GRE leads to mRNA degradation, but the ELAVL family
function as mRNA stabilizers [63]. In addition, several studies reported that UGU repeat
sequences were enriched in introns, with the same frequency as AREs [64, 65]. The authors
found significant enrichment of short UG-rich motifs in intronic regions flanking exons,
supporting a role for GRE in alternative splicing [66, 67], which activate or repress the splicing
of pre-mRNA targets through a competitive binding by MBNL and CELF proteins. This is not
surprising, as an estimated 90% of human genes produce alternatively spliced mRNA tran-
scripts [68, 69]. Alignment of the genomic regions adjacent to canonical and alternative
polyadenylation sites identified UUCUG and UGUU as conserved cis-elements, which are
essential for mRNA maturation and polyadenylation site utilization [70–73].
Thus, ARE and GRE can regulate pre-mRNA splicing, translation, and/or mRNA deadeny-
lation or decay depending on the repertoire of proteins they interact with in different intracel-
lular settings. The classification of AREs and GREs has been described in multiple manuscripts
[74–77], and an overview is shown in Table 1. Single nucleotide polymorphism studies in
humans demonstrated that SNPs in ARE and GRE sites are associated with higher risk of
human diseases that involve adaptive immune response; mutations in these conserved cis-
acting elements resulted in changes in RNA stability and binding preferences for RNA-BPs
(reviewed in ref. [44, 63, 78, 79]). The opposing effects of RNA-BP on mRNA turnover may
have important implications for the role of posttranscriptional regulation in proliferative
diseases such as cancer. Most existing data suggest that the unbalanced expression and func-
tion of ARE-BPs appears to drive neoplastic growth and proliferation and contribute to cancer
pathogenesis [44, 80]. A definitive causal connection, that is clinically relevant to human
pathology, has not yet been demonstrated.
4. Poly(A) tail and polyadenylation sequences
The addition and removal of the poly(A) tail are the rate-limiting steps of maturation and
degradation processes that the majority of mammalian mRNAs undergo [81–83]. Two tightly
coupled reactions – cleavage and polyadenylation – involve a large number of protein compo-
nents. Alternative polyadenylation of RNA is a posttranscriptional modification that plays an
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important role in gene expression, as it produces mRNAs that share the same coding region,
but differ in their 30 UTRs. This process is highly tissue specific and results in the generation of
alternative mRNA isoforms with different stability rates and translational efficiency and even
subcellular localization [84–86]. In mammals, the poly(A) cleavage/polyadenylation site is
composed of three sets of consensus cis-elements: the highly conserved AAUAAA hexamer
and less conserved U/GU-rich and UGUA elements. A bioinformatics analysis showed that an
overwhelming majority of mammalian mRNAs harbor a conserved AAUAAA or a close
canonical variant, AUUAAA, sequences [87, 88]. Flanking sequences are very important for
the poly(A) site to function [89]. For example, two downstream U/GU-rich regions are both
necessary for binding of the specific cleavage polyadenylation complex [90, 91]. A number of
trans-binding factors regulate poly(A) site utilization and the efficiency of pre-mRNA
processing in the nucleus, including five large families of CPSF, HNRNP, CF, MBNL, and
CSTF proteins as well as snoRNAs [92–95]. These families have opposing effects on
polyadenylation site utilization in nascent RNAs, determining the final pool of mature mRNA
isoforms and subsequent choreography and activity of trans-binding factors in the cytoplasm
(reviewed in [96, 97]). Immediately after cleavage, poly(A) polymerases (PAPs) promote
lengthening of the poly(A) tail, completing the mRNA maturation process [98, 99]. Genome-
wide polyadenylation site (PAS) analysis in mammalian cells identified a great diversity of
PAS utilization in different tissues and organs [73, 100]. Mutations can cause the loss of the
canonical adenylation signal and subsequent switch to alternative PAS utilization [101].
Another conserved regulatory cis-element is the cytoplasmic polyadenylation element (CPE).
Many mammalian RNAs contain a CPE, a UUUUA/U sequence, located in the 30 UTR. The
CPE serves as a binding site for cytoplasmic polyadenylation element-binding (CPEBs) pro-
teins 1–4 [102]. The most obtrusive differences in the CPE usage have been described under
conditions of stress [103].
The nuclear poly(A)-binding proteins (PABPs) act as poly(A) keepers during the mRNA
processing through first binding to newly added (A)12 nucleotides and allowing the poly(A)
tail to grow up to 250 nucleotides before the mRNA is exported into the cytoplasm [104, 105].
In the cytoplasm, the poly(A) tail acts as a cis-regulatory element and mediates mRNA trans-
lation. Recently developed methodologies make it affordable to count differentially
polyadenylated mRNAs and assess the length of the poly(A) tail [106–108]. In somatic cells,
mRNA deadenylation can lead to the degradation or stabilization of translationally silent
transcripts; however, the importance of the poly(A) tail length in these processes is currently
under scrutiny as there is an evidence that the translation is regulated independently of their
poly(A) tail length in the somatic cell cycle [109]. As for embryonic developmental processes,
translationally repressed mRNAs can be reactivated by cytoplasmic poly(A) tail elongation at
the precise time when their encoded proteins are needed to be translated [108, 110].
5. Other intermediate cis-elements
A number of ARE-like transcripts have been identified in several mammalian systems to
regulate important posttranscriptional networks of gene expression.
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Poly (U) sequences are the third most conserved cis-element after ARE and GRE, which have
been recently found within sequence composition at cross-link nucleotides site using the CLIP
assay [111]. Frequencies of poly(U) are most highly enriched for UUUUU pentanucleotides.
The HNRNPC and HNRNPD (AUF1) can recognize and bind to U sequences in pre-mRNAs,
mature mRNAs, and non-coding RNAs and influence target transcript diversity in the nucleus
through pre-mRNA splicing and the stability in the cytoplasm [41]. It is interesting to note that
clusters V of ARE and GRE elements (see Table 1) include hundreds of mRNAs harboring U-
pentanucleotides in the 30 UTR, suggesting that CELF and ELAVL families can also bind to
poly(U) tracts under certain conditions, perhaps with lower affinity [112].
Uridylation is an independent biochemical process that is facilitated by uridylation enzymes
such as ZCCHC11 and ZCCHC6. In mammalian cells, uridylation readily occurs on deadeny-
lated mRNAs through the recognition of short poly(A) tails (<25 nt). Protein PABPC1 antago-
nizes uridylation of polyadenylated mRNAs, contributing to changes in mRNA half-lives
[113]. MicroRNA can also induce uridylation of its targets; however, selectivity of mRNA
uridylation has not been decisively demonstrated. The development of novel methods, such
as TAIL-Seq, allows for genome-wide discovery of alternative mRNA tailing processes such as
uridylation and guanylation at downstream sites of shortened poly(A) tails [114]. Dynamic
control of mRNA tailing is implicated in turnover and translational control and is fundamental
for early embryonic development [115].
GC-rich sequences were also found to be conserved in coding and non-coding regions of
mammalian mRNAs. Classified as GC-rich elements (GCREs), these were identified in NCL
(nucleolin), PCBP1 and UPF protein-binding complexes [116]. GCREs regulate mRNA stabil-
ity, decay, and translational efficiency [117]. Several lines of evidence establish primary func-
tion for GCRE as regulators of mRNA transcription [118].
The CU-rich element (CURE) is a target for several RNA- or DNA-binding proteins, for
example, PCBP1 [119] and PTBP1 [120, 121] and regulates gene expression via a broad, but
poorly defined spectrum of posttranslational mechanisms.
Oligonucleotides (T/C)nGGG/G from four separate strands can be folded into stacked tertiary
structures known as G-quadruplexes, forming polymorphic loops of three G-quartet layers
with four G-tracts [122–124]. Folded G-structures (Gs)2–7 are found in 3
0 and 50 UTRs, but are
very rare in coding and intergenic regions, and could influence all aspects of RNA metabolism
[125, 126]. Studies have shown that 30 UTR G-quadruplexes can bind more than two dozen
proteins that interact with the Gs structure and serve as regulators of transcription, splicing,
processing, localization, and stability and have been recently discussed in excellent reviews
[127, 128]. Moreover, bioinformatics and computational scans have shown the prevalence of
intermolecular DNA–RNA G-quadruplexes and (Gs)4 pairing with miRNA in mammalian
cells [129, 130]. These observations imply almost endless possibilities of intermolecular inter-
actions, which undoubtedly would have significant impact on our understanding of transcrip-
tional and posttranscriptional gene expression and regulation in mammalian cells.
Internal ribosome entry sites (IRESs) are heterogeneous cis-acting regulatory elements located
primarily in 50 untranslated regions of mammalian mRNAs. IRESs facilitate alternative mRNA
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translation, skipping the need for the m7GpppN cap structure and many translation initiation
trans-acting factors in the recognition process of the translation initiation codon (e.g., AUG) by
ribosomal subunits [131]. Since the length of IRES can be several hundred nucleotides long, it
was difficult to identify IRES’ structural elements that are important for the common second-
ary structures or functions [132, 133]. In depth sequence scans through the human
transcriptome identified a variety of poly-U, poly-A, and CU-rich k-mers that seem to be
important determinants of the IRES activity [134]. These k-mers represent binding sites for
IRES trans-acting factors and are located at positions less than 150 nt upstream of the AUG
start-codon [135]. Translation initiation mediated by IRES is commonly presented as a cell
survival mechanism in response to stress; however, the significance of this process and impli-
cations to human diseases are unknown due to lack of solid in vitro experimental results that
would unambiguously demonstrate the effect in vivo [136].
Pumilio response element (PRE) is another cis-element that is well defined in nonmammalian
systems. A consensus 50- UGUANAUAwas derived from gel shift, RIP, PAR-CLIP, and crystal
structure approaches [137]. It is present in almost 3000 mammalian mRNAs and serves as a
cis-element for the PUM family of proteins [138, 139]. PUMs exert two modes of mRNA transla-
tional repression: deadenylation-mediated repression and a deadenylation-independent mecha-
nism [140].
Another novel 30 UTR motif (UAAC/GUUAU) is also prevalent (7% of mammalian 30 UTRs
contain one or more copies) and has strong species conservation [141]. This motif is a binding
target for HNRNP A2/B1 and A1 and is involved in mRNA deadenylation. A fundamental role
of UAAC/GUUAU and similar elements as regulators of the mammalian mRNA translational
activation or repression is yet to be demonstrated [142].
6. Short multivalent regulatory motifs
Mapping mammalian pre-mRNA positional enrichment of short intronic splicing regulatory
elements (ISREs) is another example of the identification of cis-acting elements that are most
important for pre-mRNA splicing. De novo searches for multivalent RNA motifs identified a
number of conserved tetra- to hexamers that mediate the position-specific combinatorial bind-
ing by RNA-binding proteins [143, 144]. The position of short motifs can predict the tissue-
specific RNA isoform abundance and can serve as an intronic splicing enhancer or silencer
during embryonic development and in adult organisms [145]. Since the consensus sequence
elements of splice sites are very short (e.g., 50-UUAGGU, AAGGAC, AAGAAC, CCUCUG,
GCUGCG, CUGCUG-30), the mechanism by which the spliceosome distinguishes them as
authentic splice sites remains a long-standing question. One of the explanations provided in
[146, 147] suggests that these sequences form specific secondary structures that increase bind-
ing affinities to RNA-binding motifs across many RNA-BPs. The strong association of ISREs
with differences in splicing patterns, but poor evolutionary conservation, suggests the role for
these motifs to act as cis-acting splice codes that allow for the progressive divergence of
alternative splicing in vertebrates [148].
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7. MicroRNAs (miRNAs)
MicroRNAs are conserved regulatory sequences that pervasively act, in trans, toward mRNA.
miRNA-binding sites are important regulators of mRNA half-life and activity. The majority of
miRNAs influence mRNA life span through biochemical interactions with mRNA and/or
RNA-BPs [149]. This could be achieved through direct competition for a shared binding site
or through remodeling of the mRNA structure to favor (or impede) miRNA association nearby
[150]. In support of this, a recent bioinformatics analysis determined that UUUGUUU motifs,
which bear an uncanny resemblance to GRE-binding sites, are enriched in the adjacent to
many miRNA-binding sites, and their presence tends to augment miRNA activity [151]. On
the other hand, any miRNA that contains a UGUKUGU or UAUKUAU seed sequences (K
represents G or U) could in theory bind and occlude GRE-BP- or ARE-BP-binding motifs,
which prevent any interaction with cis-elements within mRNA. For example, the mir-122
interaction with CELF1 has been demonstrated, proposing that CELF1 can play a role in the
degradation of GRE-containing miRNAs [152]. It has been computed that the proximity of
RNA-BP-binding sites and residues pairing to miRNA can quantitatively predict mRNA cis-
element performance for several intensely studied RNA-BPs and miRNAs [153–155]. Although
mechanistic details of interplay between cis-acting elements, RNA-BPs, and miRNAs are
understudied, they perhaps should be a high priority, given recent observations that miRNA
expression and/or processing are affected in many human diseases and disorders [156–158].
Significant progress has been made by bioinformaticians and biologists to better understand
system biology of the RNA life cycle; several useful metadata hubs were created, which
incorporate existing experimental data and computational approaches [159, 160]. The compre-
hensive list of available software and websites has been recently reviewed in Ref. [161]. How-
ever, we are still far from having a comprehensive understanding of mechanisms of RNA
biogenesis and its relevance in physiological and pathological conditions.
8. Pathological cis-elements
The human genome contains a large number of short repetitive sequences that are prone to
higher than average mutation rates and transcriptional errors [162], which can engender a
tandem repeat expansion in cis-acting elements of 30 or 50 UTR, introns, or coding regions, and
cause a large variety of inherited human diseases. For example, endogenous nucleotide repeat
expansions are implicated in many human autosomal dominant diseases and have emerged as
new groups of repeat expansion disorder associated with tri- or pentanucleotide repeat expan-
sion pathogenesis. Pathological repeats can elicit toxicity that is triggered by toxic RNA or
abnormally translated protein dipeptide or homopolymeric peptides [163]. Disorders as such
include, but are not limited to the following conditions:
• Spinocerebellar ataxia (SCAs types 1–37) is the largest and the most diverse group of
inherited neurological diseases in which neurological dysfunction is driven by defects
known as ataxias. Several mutations in tandem repeat expansions were discovered,
including coding (CAG)n mutations in SCA1, 2, 3, 6, 7, and 17 genes; non-coding (CTG)n
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in SCA8 [164]; non-coding (CAG)n in SCA12; (ATTCT)n – in SCA10; (TGGAA)n – in
SCA31; and (GGCCTG) – in SCA36 (please see OMIM.org for details).
• Myotonic dystrophies (DM), where (DM1) is associated with >300 CUG, repeats in the
DMPK mRNA; and (DM2) – with >CCUG repeats in ZF9 mRNA [165].
• Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia are associated with
GGGGCC/CCCCGG repeat expansion in the non-coding region of the C9orf72 (C9ALS/
FTD) gene [166].
• Huntington’s disease is caused by CAG expansion repeats in the HTT gene [167];
• Fragile X syndrome (FXS) arises when the FMR1 gene reach <230 CGG repeats.
• Fragile X-associated tremor/ataxia syndrome (FXTAS) is associated with CGG/CCG
repeat expansion in the fragile X gene, FMR1 [168].
Molecular pathogenesis of endogenous nucleotide repeat expansion diseases is complicated and
pertained to the presence of repeat-associated non-AUG translation (RAN), where translation of
mutant polypeptides is initiated without an AUG-initiation codon or it is driven by the open
reading frame shifts due to expanded three-base-pair repeats during skipped mispairing in the
course of DNA synthesis (reviewed in [169, 170]). Although the posttranscriptional modification
state of these transcripts (e.g., mRNA capping and polyadenylation) is unknown, two transla-
tional pathways are described: (1) ATG-initiated translation produces multiple polypeptides if
there are multiple ORFs within the transcript. (2) RAN translation of the expanded repeat can
produce up to six distinct RAN polypeptides: poly-Gln, poly-Ala, and poly-Ser RAN proteins
(from CTG/CAG repeats); and poly-Leu, poly-Ala and poly-Cys polypeptides from the CAG/
CUG repeat mRNA. Repeats located in antisense transcripts of above listed genes are also
substrates for RAN translation, further expanding the number of pathological dipeptides or
homopolymeric RAN proteins produced during disease pathogenesis.
An interesting common aspect of these pathologies is that they are caused by mutated cis-
elements and are often produced through bidirectional transcription. Resultant toxic RNA
causes intracellular stress and sequestration of RNA-BPs toward expanded sequence repeats
[171], which changes the biochemistry of posttranscriptional regulatory networks in affected
tissues. The abovementioned diseases represent an incomplete list of a growing number of
disorders that can potentially have similar therapeutic opportunities. The recently developed
‘base editor’ CRISPR-Cas9 methodology has demonstrated a high power of nucleotide-level
precision editing, making this approach suitable for repeat excision as genetic therapies for the
above listed conditions [172] and may also correct many other RNA pathologies, for example,
those driven by nonsense-mediated mRNA decay [173].
9. Models for the effects of cis-acting elements
mRNA molecules move through different cellular compartments within messenger ribonu-
cleoprotein (mRNP) complexes in dynamic association with RNA-binding proteins that bind
to conserved cis-elements shared by subsets of transcripts [174]. The association of specific
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coordinates the fate of these bound transcripts through posttranscriptional processes such as
splicing, intracellular localization, translation, storage, or mRNA decay [175, 176]. Not surpris-
ingly, very few transcripts have only one type of regulatory element. Focusing on individual
scenarios, we built a concise predictive model of higher-order complexes that can be formed
simultaneously within different cellular compartments, starting in from the nucleus and mov-
ing into the cytoplasm.
A. Regulation of splicing by cis-elements (Figure 1A):
The cis-elements within precursor RNA are catalyzed by different components of the
spliceosome during constitutive splicing events [177]. Binding by RNA-BP to short intronic
splicing regulatory elements (ISREs) regulates exon inclusion or exon skipping during stage-
specific constitutive splicing transitions, in a position-dependent manner [67]. These pro-
cesses are orchestrated by biochemical recognition and binding on a competitive basis by a
family of U proteins that compose the spliceosome.
RNA-BPs also bind to multivalent intronic sequences in precursor mRNA and regulate the
alternative splicing (e.g., exon skipping, alternative splice site retention, or intron reten-
tion). Alternatively-spliced transcripts may contain different 30 or 50 UTRs that can be
subject to differential translational regulation of mature transcripts. An important regula-
tors of alternative splicing efficiency are PTBP, SR, RBM, and HNRNP families of proteins
and snRNAs. The use of alternative exons leads to the production of transcripts with
different open reading frames (ORFs) and diversifies the repertoire of encoded proteins,
giving rise to protein isoforms with alternative N- and C- termini.
B. Regulation of adenylation by cis-acting elements (Figure 1B):
Alternative polyadenylation (APA) occurs in a tandem manner with splicing. Many splic-
ing factors are also 30-end processing factors within the mRNA 30-end cleavage and
polyadenylation (CPA) complexes. The recognition of cis-elements upstream of canonical
or alternative PAS serves as a docking site for specific RNA-binding proteins (e.g., CPSF,
CF, CSTFs, HNRNPs, MBNL, and CPEB), which in turn recruit canonical poly(A) poly-
merases (PAPOL). The CPA complex requires stabilization by a downstream GU/GC-rich
sequence element (DSE) and its interaction with the CPSF-processing factors. The
upstream sequence element (USE) is U-rich and serves an auxiliary role, binding to CF
and PAPOL, and also stabilizes the cleavage complex.
The cleavage and polyadenylation specific factor (CPSF) binds weaker noncanonical
polyadenylation (AUUAAA) signals and cuts at the proximal polyadenylation site (PAS).
The utilization of distal canonical PAS results in the processing of the full mature tran-
script. Cleavage at the proximal PAS leads to shortening of the 30 untranslated region and
loss of regulatory sequences within the 30 UTR (e.g., ARE or GRE or miRNA-binding
sites). MBNL can mask the region upstream of weak noncanonical PA signals, blocking
the binding of cleavage factor I (CF).
The CPEB1 protein binds the cytoplasmic polyadenylation element (CPE, consensus
sequence 50-UUUUUAU -30) located upstream of non-canonical PA signals within the
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mRNA and shuttles it into the cytoplasm. The cytoplasmic CPEB1-CPE complex recruits
poly(A) polymerase (PAP), which promotes the lengthening of the poly(A) tail and
increases translation efficiency. The greater the distance between CPE and poly(A) tails of
transcripts, the weaker the rate of adenylation.
C. Regulation of translation by cis-acting elements (Figure 1C):
Most eukaryotic mRNAs are translated by the cap-dependent mechanism, which requires
recognition of the cap structure (m7GpppN) at the 50 end by early initiation factor com-
plexes (eIFs). EIFs recruit ribosomal subunits and initiator Met-tRNA and scan along the
Figure 1. Predictive scenarios of cis-element effects and trans-binding factors behavior on mRNA splicing, adenylation,
translation, and decay. Blunt arrows indicate direct suppression; arrows represent activation. These figures are made by
using the ingenuity pathway analysis software based upon the observations from previous studies or suggested regula-
tory mechanisms. A. Consensus multivalent sequences represent the intronic splice sites that are recognized by a family of
small nuclear ribonucleoproteins (U snRNPs). These regulatory cis-elements can be divided into two types: (1) intronic
regions which almost always begin with the dinucleotide GU and end with AG; and (2) intronic regions which have either
AU and AC termini or GU and AG termini. Introns are also rich with pyrimidine nucleotides that cumulatively compose a
pyrimidine binding tract, which also have a unique poly(A) branch point sequence upstream. Of the other four types of
cis-acting elements: two are located within exons (exonic splicing enhancers, ESEs, and exonic splicing silencers, ESSs), and
two are located within introns (intronic splicing enhancers, ISEs, and intronic splicing silencers, ISSs). The key trans-acting
splicing factors are shown: SR, serine/arginine-rich (SR) proteins; U1 small nuclear ribonucleoproteins (U1 snRNPs);
HNRNPs, heterogeneous nuclear ribonucleoproteins; PTB, polypyrimidine tract binding protein. B. Adenylation of pre-
mRNA is triggered by cis-regulatory sequences named poly(A) signals: AAUAAA or/and AUUAAA; the U/GU-rich and
UGUA elements. By direct analogy to splicing, canonical adenylation is regulated by RNA-BPs or snRNAs. CF, cleavage
factor; CSTF, cleavage stimulation factor; CPSF, cleavage polyadenylation specificity factor; MBNL, muscle blind like
protein; PAP, poly(A) polymerase; PABP, poly(A) binding protein; CPEB, cytoplasmic polyadenylation element binding
protein; miRNA BS, miRNA binding sites; S RNA-BP, stabilizing RNA-binding protein; D RNA-BP, destabilizing RNA-
binding protein; CPA, cleavage polyadenylation assembly; CPE, cytoplasmic polyadenylation element. C. Cis-mediated
regulation of canonical and alternative translation includes sequences in all parts of mRNA. In canonical translation, the
initiation factors (RNA-BPs) bind the 50 m7GpppN cap, and then linearly scan through the 50 UTR until reaching an AUG
start codon. For simplicity, the components of the translation machinery are shown as eIF2 and eIFs (eukaryotic early
translation initiation factors). PABP, poly(A) binding protein; IRES, internal ribosomal entry site; P, phosphorylation of
RNA-BP. D. Schematic illustration of the cytoplasmic mRNA decay complex formation. The details for this scenario are
provided in the text. S RNA-BP, stabilizing RNA-binding proteins; D RNA-BP, destabilizing RNA-binding proteins; PABP,
poly(A)-binding protein; eIF2 and eIFs, eukaryotic early translation initiation factors. E. Scenarios for miRNA mediated
mRNA translational repression or decay pathways. The details for this scenario are provided in the text. RISC, RNA-
induced silencing complex; P, phosphorylation of RNA-BP.
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50 UTR of the mRNA to reach the start codon (an AUG triplet). During the scanning, the
secondary RNA structure unwinds in an ATP-dependent manner. The 50 UTR is rich in
GC-content and is prone to folding into secondary structures, which may hinder ribo-
somal assembly [178]. Hairpin loops as secondary structure regulatory elements were
described only for a handful of mRNAs, and their role in genome-wide translation is not
known. A combination of new ribo-sequencing with fluorescent visualization might shed
light on the role of hairpin loops in translation in the near future [179–182]. Other internal
50 UTR cis-element structures are AREs and GREs. Their effects on translation are medi-
ated by a combination of RNA-BPs. They are often found to be part of hairpin loops.
Visualizing a folded hairpin structure in vivo is not possible at current resolution limits.
The translation initiation via internal ribosomal entry site (IRES) occurs in a cap-
independent manner. Mammalian IRES facilitates bypassing of the eIF4E-m7GpppN cap
interaction and recruitment of the small and large ribosomal subunits and tRNA to the
transcript, initiating translation at the canonical AUG start codon.
G-quadruplexes within/near IRES may potentiate alternative translation. However, G4
structures in 30 or 50 UTRs and an open reading frame mainly repress cap-dependent
translation (reviewed in Ref. [183]).
The poly(A) tail also plays a role in translation as an mRNA stabilizer and a facilitator of
mRNA circularization, which promotes translation. De-adenylation processes tend to
slowdown the translation rate and eventually lead to mRNA degradation.
D. Regulation of mRNA stabilization or decay by cis-acting elements (Figure 1D):
In mammalian cells, mRNA stabilization or decay is regulated by cis-elements in the 30
UTR. Numerous known RNA-BPs serve as trans-binding factors for ARE/GRE and other
elements to facilitate transcript deadenylation and subsequent decay by exonucleases.
There are also a number of RNA-BPs with the opposite function, which stabilize and
promote mRNA translation. Posttranslational alteration of RNA-BPs (particularly within
RNA-binding domains) can lead them to dissociate from RNA-binding complexes, and be
replaced by other competitors, thereby contributing to mRNA de/stabilization [76]. A fine-
tuned balance must be reached in cells for proper function at the organismal level.
E. Interplay between mRNA, miRNA and RNA-BPs (Figure 1E):
The estimates on how different miRNA and mRNA are loaded into the RNA-BP-bound
RISC (RNA-induced silencing complex) were derived from CLIP assays results [184–186].
Several scenarios are possible to extract from these: If both miRNA and RNA-BP are
bound to the 30 UTR of mRNA, they will be sufficiently close to each other and the
complex can be identified by CLIP. They would work cooperatively to promote the
assembly of decay machinery. Independent binding by a competitor RNA-BP might
disrupt this complex. The strength of miRNA-mRNA canonical and noncanonical bond
formation can be computed to project possible biochemical outcomes [187–189].
The mRNA 30 UTR length and secondary structure formation can greatly influence both
miRNA and RNA-BP-binding efficiency; it can also disrupt or assuage the assembly of
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RNA-BP complexes by providing high affinity or multioccupancy binding sites. The out-
comes of this scenario could be anywhere from marginal translational repression to
accelerated mRNA degradation.
Cis-acting sequences within miRNAs that resemble cis-elements (ARE or GRE) have
perfect complementarity to RNA-BP’s RNA-recognition motifs (RRMs). They can, in
theory, occlude RRM-binding sites, acting as alternative inhibitors of RNA-BP activity.
This could potentiate (or hinder) translational repression and mRNA degradation of
target mRNA, depending on which RNA-BP was affected.
10. Conclusions and perspectives
Examples given in this chapter suggest that mRNA regulation is important in multiple aspects
of mammalian biology; however, it is largely unknown how the combinatorial regulation is
achieved at the biological complexity of the organisms. Transcriptome-wide mapping of cis-
elements and trans-binding sites demonstrates huge regulatory potentials for non-coding parts
of mRNA. The more details we learn about cross-talk, molecular assembly, and compartmen-
talization of RNA-protein complexes, the more unifying principles we may find. Understand-
ing of the factors and elements involved in the regulation of a particular gene expression in a
single cell [190] is of paramount importance when designing molecular therapies or when
attempting to modulate the expression of a target gene. Thus, scientists and geneticists have
exciting opportunities ahead in the field of therapeutic genome editing.
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